Suppression of NUAK1 is synthetic lethal with MYC overexpression, suggesting that NUAK1 may present an attractive target for treatment of MYC-driven cancers.21, 38 A thorough understanding of the signal transduction context of NUAK1 will be crucial to determine if such a strategy is feasible in human subjects. The gene discussed is MYC; the disease is cancer.